T cell-based HIV gene therapy safe over long term
(HealthDay) -- T cell-based gene therapy for HIV seems safe, with no evidence of vector-induced cell immortalization more than a decade after treatment, according to a study published in the May 2 issue of ...
HIV & AIDS
May 07, 2012 |
5 / 5 (1) |
0
|
Study using stem cell therapy shows promise in fight against HIV
UC Davis Health System researchers are a step closer to launching human clinical trials involving the use of an innovative stem cell therapy to fight the virus that causes AIDS.
HIV & AIDS
May 02, 2012 |
5 / 5 (6) |
0
|
Anti-HIV drug use during pregnancy does not affect infant size, birth weight
Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens ...
HIV & AIDS
May 02, 2012 |
not rated yet |
0
|
Progress against HIV thwarted by patients' unmet needs
In a groundbreaking study published last year, scientists reported that effective treatment with HIV medications not only restores health and prolongs life in many HIV-infected patients, but also curtails transmission to ...
HIV & AIDS
Apr 26, 2012 |
not rated yet |
0
|
Longer breastfeeding along with antiretroviral drugs could lower HIV transmission to babies
In early results of a large-scale randomized study published in 2010 and led by researchers from the University of North Carolina at Chapel Hill, giving daily antiretroviral drugs (ART) to HIV-infected moms ...
HIV & AIDS
Apr 25, 2012 |
not rated yet |
0
|
Mechanism of HIV spread has potential for future drug therapy
A new understanding of the initial interactions of human immunodeficiency virus type 1 (HIV-1) and dendritic cells is described by Boston University School of Medicine (BUSM) researchers in a study currently featured in the ...
HIV & AIDS
Apr 23, 2012 |
not rated yet |
0
|
Pill to block HIV slated for testing
California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state, researchers announced Tuesday.
HIV & AIDS
Apr 23, 2012 |
not rated yet |
0
Giving preventive drug to men at high risk for HIV would be cost-effective, study shows
A once-a-day pill to help prevent HIV infection could significantly reduce the spread of AIDS, but only makes economic sense if used in select, high-risk groups, Stanford University researchers conclude in a new study.
HIV & AIDS
Apr 16, 2012 |
not rated yet |
0
|
Possible clues found to why HIV vaccine showed modest protection
Insights into how the first vaccine ever reported to modestly prevent HIV infection in people might have worked were published online today in the New England Journal of Medicine. Scientists have found that among adults who re ...
HIV & AIDS
Apr 04, 2012 |
3 / 5 (2) |
0
|
HIV 'superinfection' boosts immune response
Women who have been infected by two different strains of HIV from two different sexual partners – a condition known as HIV superinfection – have more potent antibody responses that block the replication of the virus ...
HIV & AIDS
Mar 29, 2012 |
5 / 5 (3) |
0
|
Deeper view of HIV reveals impact of early mutations
Mutations in HIV that develop during the first few weeks of infection may play a critical role in undermining a successful early immune response, a finding that reveals the importance of vaccines targeting regions of the ...
HIV & AIDS
Mar 08, 2012 |
4.5 / 5 (2) |
0
|
HIV/AIDS vaccine shows long-term protection against multiple exposures in non-human primates
An Atlanta research collaboration may be one step closer to finding a vaccine that will provide long-lasting protection against repeated exposures to human immunodeficiency virus (HIV). Scientists at Emory University and ...
HIV & AIDS
Mar 07, 2012 |
5 / 5 (1) |
0
|
Study finds HIV-specific CD4 cells that control viral levels
A subpopulation of the immune cells targeted by HIV may play an important role in controlling viral loads after initial infection, potentially helping to determine how quickly infection will progress. In the February 29 issue ...
HIV & AIDS
Feb 29, 2012 |
5 / 5 (1) |
0
|
Researchers discover new HIV vaccine-related tool
(Medical Xpress) -- A new discovery involving two Simon Fraser University scientists could lead to a little known and benign bacterium becoming a vital new tool in the development of a vaccine against human ...
HIV & AIDS
Feb 23, 2012 |
5 / 5 (1) |
0
|
Prevalence of improper condom use a public health issue worldwide: researchers
Problems with the correct use of the male condom, such as not wearing a condom throughout sex or putting it on upside down, are common in the U.S. and have become a major concern of public health officials. New research shows ...
HIV & AIDS
Feb 22, 2012 |
not rated yet |
0
|
